amfAR, The Foundation for AIDS Research
amfAR plays a vital role in AIDS research, identifying critical gaps in our knowledge of HIV and AIDS, and supporting groundbreaking studies that often lack the preliminary data required by more traditional funders.
amfAR’s Scientific Advisory Committee Chair on his new role, his research interests, and the prospects for curing HIV.
Plan Includes $20 Million, Five-Year Grant to Establish and Fund a Cure-Focused HIV/AIDS Research Institute
Our goal is to develop the scientific basis for a cure by the end of 2020.
Leading amfAR-funded researchers gathered in New York City to report on progress toward an HIV/AIDS cure.
New research suggests a certain immune defense against HIV may be doing more harm than good.
The amfAR Research Consortium on HIV Eradication, or ARCHE, is enabling teams of researchers to collaborate.
The immune system’s first-line defenses are crude but essential to fighting many infectious diseases. But new research suggests one of these early defense systems may be doing more harm than good.
Researchers have developed a method to enhance the ability of antibodies to target and kill HIV-infected cells.
© 2015 amfAR All Rights Reserved